Home LiteratureArticle Details
PMID: 15026807 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene.

British journal of cancer ·Vol. 90 ·No. 6 ·2004-03-22 ·Pages 1235-43

Wykoff CC, Sotiriou C, Cockman ME, Ratcliffe PJ, Maxwell P, Liu E, Harris AL

Abstract

Gene expression analysis was performed on a human renal cancer cell line (786-0) with mutated VHL gene and a transfectant with wild-type VHL to analyse genes regulated by VHL and to compare with the gene programme regulated by hypoxia. There was a highly significant concordance of the global gene response to hypoxia and genes suppressed by VHL. Cyclin D1 was the most highly inducible transcript and 14-3-3 epsilon was downregulated. There were some genes regulated by VHL but not hypoxia in the renal cell line, suggesting a VHL role independent of hypoxia. However in nonrenal cell lines they were hypoxia regulated. These included several new pathways regulated by hypoxia, including RNase 6PL, collagen type 1 alpha 1, integrin alpha 5, ferritin light polypeptide, JM4 protein, transgelin and L1 cell adhesion molecule. These were not found in a recent SAGE analysis of the same cell line. Hypoxia induced downregulation of Cyclin D1 in nonrenal cells via an HIF independent pathway. The selective regulation of Cyclin D1 by hypoxia in renal cells may therefore contribute to the tissue selectivity of VHL mutation.

MeSH Terms
Carcinoma, Renal Cell/genetics,pathology Cell Hypoxia Cyclin D1/pharmacology Gene Expression Profiling Humans Kidney Neoplasms/genetics,pathology Tumor Cells, Cultured Tumor Suppressor Proteins/genetics Ubiquitin-Protein Ligases/genetics Von Hippel-Lindau Tumor Suppressor Protein
Chemicals
Tumor Suppressor Proteins Cyclin D1 Ubiquitin-Protein Ligases Von Hippel-Lindau Tumor Suppressor Protein VHL protein, human
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Wykoff C C
Molecular Oncology Laboratories, John Radcliffe Hospital, Weatherall Institute of Molecular Medicine, Cancer Research UK, Oxford OX3 9DS, UK.
Sotiriou C
Cockman M E
Ratcliffe P J
Maxwell P
Liu E
Harris A L
References (27)
27 references, click to expand
  1. 14-3-3 proteins: key regulators of cell division, signalling and apoptosis.
    Bioessays. 2001 Oct;23(10):936-46 PMID: 11598960
  2. Transcriptional response to hypoxia in human tumors.
    J Natl Cancer Inst. 2001 Sep 5;93(17):1337-43 PMID: 11535709
  3. VHL-mediated hypoxia regulation of cyclin D1 in renal carcinoma cells.
    Cancer Res. 2002 Jun 1;62(11):3014-9 PMID: 12036906
  4. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Cancer Res. 2002 Jul 1;62(13):3803-11 PMID: 12097293
  5. Cis and trans interactions of L1 with neuropilin-1 control axonal responses to semaphorin 3A.
    EMBO J. 2002 Dec 2;21(23):6348-57 PMID: 12456642
  6. Gene expression profiling in a renal cell carcinoma cell line: dissecting VHL and hypoxia-dependent pathways.
    Mol Cancer Res. 2003 Apr;1(6):453-62 PMID: 12692265
  7. Analysis of gene expression in single live neurons.
    Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):3010-4 PMID: 1557406
  8. Identification of the von Hippel-Lindau disease tumor suppressor gene.
    Science. 1993 May 28;260(5112):1317-20 PMID: 8493574
  9. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype.
    Hum Mutat. 1995;5(1):66-75 PMID: 7728151
  10. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein.
    Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10595-9 PMID: 8855223
  11. Selection and analysis of a mutant cell line defective in the hypoxia-inducible factor-1 alpha-subunit (HIF-1alpha). Characterization of hif-1alpha-dependent and -independent hypoxia-inducible gene expression.
    J Biol Chem. 1998 Apr 3;273(14):8360-8 PMID: 9525945
  12. Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha.
    Blood. 1998 Oct 1;92(7):2260-8 PMID: 9746763
  13. Cyclin D1 expression in renal carcinomas and oncocytomas: an immunohistochemical study.
    Mod Pathol. 1998 Nov;11(11):1075-81 PMID: 9831205
  14. Cluster analysis and display of genome-wide expression patterns.
    Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14863-8 PMID: 9843981
  15. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.
    Nature. 1999 May 20;399(6733):271-5 PMID: 10353251
  16. Cyclin-D1 expression in human renal-cell carcinoma.
    Int J Cancer. 1999 Jun 21;84(3):268-72 PMID: 10371345
  17. Selective activation of p38alpha and p38gamma by hypoxia. Role in regulation of cyclin D1 by hypoxia in PC12 cells.
    J Biol Chem. 1999 Aug 13;274(33):23570-6 PMID: 10438538
  18. Molecular analysis of selected cell cycle regulatory proteins during aerobic and hypoxic maintenance of human ovarian carcinoma cells.
    Br J Cancer. 1999 Aug;80(12):1875-83 PMID: 10471034
  19. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
    Br J Cancer. 1999 Aug;80(12):2001-7 PMID: 10471053
  20. Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex.
    Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12436-41 PMID: 10535940
  21. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1.
    Annu Rev Cell Dev Biol. 1999;15:551-78 PMID: 10611972
  22. Candidate genes for the hypoxic tumor phenotype.
    Cancer Res. 2000 Feb 15;60(4):883-7 PMID: 10706099
  23. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein.
    J Biol Chem. 2000 Aug 18;275(33):25733-41 PMID: 10823831
  24. A global geometric framework for nonlinear dimensionality reduction.
    Science. 2000 Dec 22;290(5500):2319-23 PMID: 11125149
  25. Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling.
    Oncogene. 2000 Dec 14;19(54):6297-305 PMID: 11175344
  26. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.
    Science. 2001 Apr 20;292(5516):464-8 PMID: 11292862
  27. Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization.
    Br J Cancer. 2001 Nov 2;85(9):1372-82 PMID: 11720477
Article Info
Journal
British journal of cancer
Abbr.
Br J Cancer
ISSN
0007-0920
Published
2004-03-22
Pages
1235-43
Language
English
Region
England
NLM ID
0370635
PMCID
PMC2409644
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com